Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer

Genetic Testing and Molecular Biomarkers

Volumn 18, Issue 4, 2014, Pages 229-235

  Lee, Ji Hyun ^a   Cragun, Deborah ^a   Thompson, Zachary ^a   Coppola, Domenico ^a   Nicosia, Santo V ^b   Akbari, Mohammad ^c   Zhang, Shiyu ^c   McLaughlin, John ^d   Narod, Steven ^c   Schildkraut, Joellen ^e   Sellers, Thomas A ^a   Pal, Tuya ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DNA EXTRACTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MIDDLE AGED; MISMATCH REPAIR; OVARY CARCINOMA; PATHOLOGIST; STAINING; AGED; BASE MISPAIRING; DNA REPAIR; GENETICS; NEOPLASM; OVARY TUMOR;

AGED; BASE PAIR MISMATCH; DNA REPAIR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS;

EID: 84897500358     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0393     Document Type: Article

References (45)

1. Akiyama Y, Sato H, Yamada T, et al. (1997) Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 57:3920-3923.
2. American Cancer Society (2013) Cancer facts and figures 2013. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-036845 .pdf. Accessed May 20, 2013.
3. Aysal A, Karnezis A, Medhi I, et al. (2012) Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Am J Surg Pathol 36:163-72.
4. Bankfalvi A, Boecker W, Reiner A (2004). Comparison of automated and manual determination of HER2 status in breast cancer for diagnostic use: a comparative methodological study using the Ventana BenchMark automated staining system and manual tests. Int J Oncol 25:929-935.
5. Bartley AN, Luthra R, Saraiya DS, et al. (2012) Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing. Cancer Prev Res (Phila) 5:320-327.
6. Baudhuin LM, Burgart LJ, Leontovich O, et al. (2005) Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. Fam Cancer 4:255-265.
7. Boland CR, Thibodeau SN, Hamilton SR, et al. (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257.
8. Bronner CE, Baker SM, Morrison PT, et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:258-261.
9. Cai KQ, Albarracin C, Rosen D, et al. (2004) Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma. Hum Pathol 35:552-559.
10. Caliman LP, Tavares RL, Piedade JB, et al. (2012) Evaluation of microsatellite instability in women with epithelial ovarian cancer. Oncol Lett 4:556-560.
11. Chiaravalli AM, Furlan D, Facco C, et al. (2001) Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences. Virchows Arch 438:39-48.
12. Cicek MS, Lindor NM, Gallinger S, et al. (2011) Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population-and clinicbased colorectal tumors results from the Colon Cancer Family Registry. J Mol Diagn 13:271-281.
13. Coppola D, Nicosia SV, Doty A, et al. (2012) Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer. Anticancer Res 32: 4963-4969.
14. Domanska K, Malander S, Masback A, et al. (2007) Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40. Int J Gynecol Cancer 17:789-793.
15. Engel C, Loeffler M, Steinke V, et al. (2012) Risks of less common cancers in proven mutation carriers with Lynch syndrome. J Clin Oncol. 30:4409-4415.
16. Evaluation of Genomic Applications in Practice and Prevention Working Group (2009) Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11:35-41.
17. Geisler JP, Goodheart MJ, Sood AK, et al. (2003) Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer 98:2199-2206.
18. Goldstein NS, Bosler D (2007) An approach to interpreting immunohistochemical stains of adenocarcinoma in small needle core biopsy specimens: the impact of limited specimen size. Am J Clin Pathol 127:273-281.
19. Gras E, Catasus L, Arguelles R, et al. (2001) Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Cancer 92:2829-2836.
20. Ichikawa Y, Lemon SJ, Wang S, et al. (1999) Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members. Cancer Genet Cytogenet 112:2-8.
21. Khalique L, Ayhan A, Weale ME, et al. (2007). Genetic intratumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours. J Pathol 211:286-295.
22. Leach FS, Nicolaides NC, Papadopoulos N, et al. (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225.
23. Liu J, Albarracin CT, Chang KH, et al. (2004) Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer. Mod Pathol 17:75-80.
24. Malander S, Ridderheim M, Masback A, et al. (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40:422-428.
25. Miyaki M, Konishi M, Tanaka K, et al. (1997) Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17:271-272.
26. Murphy MA, Wentzensen N (2011) Frequency of mismatch repair deficiency in ovarian cancer: a systematic review. Int J Cancer 129:1914-1922.
27. O'Leary TJ (2001) Standardization in immunohistochemistry. Appl Immunohistochem Mol Morphol 9:3-8.
28. Pal T, Akbari MR, Sun P, et al. (2012) Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer. Br J Cancer 107:1783-1790.
29. Pal T, Permuth-Wey J, Betts JA et al. (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104:2807-2816.
30. Pal T, Permuth-Wey J, Kumar A, et al. (2008a) Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology. Clin Cancer Res 14:6847-6854.
31. Pal T, Permuth-Wey J, Sellers TA (2008b) A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer. Cancer 113:733-742.
32. Palomaki GE, McClain MR, Melillo S, et al. (2009) EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 11:42-65.
33. Pande M, Wei C, Chen J, et al. (2012) Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry. Fam Cancer 11:441-447.
34. Papadopoulos N, Nicolaides NC, Wei YF, et al. (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629.
35. Resnick KE, Hampel H, Fishel R, et al. (2009) Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. Gynecol Oncol 114: 128-134.
36. Risch HA, McLaughlin JR, Cole DE, et al. (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700-710.
37. Rosen DG, Cai KQ, Luthra R, et al. (2006) Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma. Mod Pathol 19:1414-1420.
38. Seidal T, Balaton AJ, Battifora H (2001) Interpretation and quantification of immunostains. Am J Surg Pathol 25:1204-1207.
39. Singer G, Kallinowski T, Hartmann A, et al. (2004) Different types of microsatellite instability in ovarian carcinoma. Int J Cancer 112:643-646.
40. Strathdee G, Appleton K, Illand M, et al. (2001) Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am J Pathol 158: 1121-1127.
41. Ueda H, Watanabe Y, Nakai H, et al. (2005) Microsatellite status and immunohistochemical features of ovarian clear-cell carcinoma. Anticancer Res 25:2785-2788.
42. Wenham RM, Schildkraut JM, McLean K, et al. (2003) Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer. Clin Cancer Res 9:4396-4403.
43. Wick MR, Mills SE (2001) Consensual interpretive guidelines for diagnostic immunohistochemistry. Am J Surg Pathol 25: 1208-1210.
44. Win AK, Lindor NM, Young JP, et al. (2012) Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst 104:1363-1372.
45. Wu Y, Berends MJ, Mensink RG, et al. (1999) Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 65:1291-1298.